LPL Financial
DNA icon

LPL Financial’s Ginkgo Bioworks DNA Stock Holding History

LPL Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$604K Buy
47,115
+4,001
+9% +$32.6K ﹤0.01% 4948
2026
Q2 		$427K Sell
43,114
-402
-0.9% -$3.36K ﹤0.01% 5156
2026
Q1 		$267K Buy
43,516
+11,989
+38% +$100K ﹤0.01% 5276
2025
Q4 		$262K Sell
31,527
-886
-3% -$9.5K ﹤0.01% 5251
2025
Q3 		$473K Buy
32,413
+951
+3% +$11.4K ﹤0.01% 4676
2025
Q2 		$354K Buy
31,462
+9,099
+41% +$70.5K ﹤0.01% 4653
2025
Q1 		$127K Buy
22,363
+3,434
+18% +$35K ﹤0.01% 4985
2024
Q4 		$186K Sell
18,929
-4,988
-21% -$42.8K ﹤0.01% 4836
2024
Q3 		$195K Buy
23,917
+9,124
+62% +$91.4K ﹤0.01% 4733
2024
Q2 		$198K Buy
14,793
+590
+4% +$17.6K ﹤0.01% 4573
2024
Q1 		$659K Buy
14,203
+2,279
+19% +$118K ﹤0.01% 3548
2023
Q4 		$806K Buy
11,924
+1,675
+16% +$103K ﹤0.01% 3250
2023
Q3 		$742K Buy
10,249
+3,184
+45% +$255K ﹤0.01% 3167
2023
Q2 		$526K Buy
7,065
+1,851
+36% +$110K ﹤0.01% 3403
2023
Q1 		$277K Buy
5,214
+619
+13% +$39.2K ﹤0.01% 3802
2022
Q4 		$311K Buy
4,595
+211
+5% +$19.4K ﹤0.01% 3623
2022
Q3 		$547K Buy
4,384
+1,762
+67% +$210K ﹤0.01% 3071
2022
Q2 		$250K Buy
+2,622
New +$320K ﹤0.01% 3774
2022
Q1 		– Sell
-349
Closed -$116K – 4245
2021
Q4 		$116K Sell
349
-107
-23% -$50.8K ﹤0.01% 4117
2021
Q3 		$212K Buy
+456
New +$222K ﹤0.01% 3937

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial's DNA Position: Q3 2026 in Review

LPL Financial increased its Ginkgo Bioworks (DNA) stake by 9.3% in Q3 2026, buying an estimated $32.6K and bringing the position to 47,115 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #4948.

LPL Financial first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $806K in Q4 2023. 76 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • LPL Financial held 47,115 shares of Ginkgo Bioworks worth $604K as of Q3 2026.
  • LPL Financial bought 4,001 Ginkgo Bioworks shares in Q3 2026, an estimated $32.6K.
  • Ginkgo Bioworks made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4948 holding.
  • LPL Financial first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • LPL Financial's Ginkgo Bioworks position peaked at $806K in Q4 2023.
  • 76 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.